The substance referred to as "CB1/2 receptor-1" with the CAS number 1260669-31-5 is a synthetic compound that acts as a cannabinoid receptor agonist. It is designed to interact with the cannabinoid receptors CB1 and CB2, which are part of the endocannabinoid system in the body. These receptors play crucial roles in various physiological processes, including pain sensation, mood regulation, and immune response. The compound is typically characterized by its ability to modulate neurotransmitter release and influence various signaling pathways. Its pharmacological profile may include analgesic, anti-inflammatory, and neuroprotective effects, making it of interest in therapeutic research, particularly in the context of pain management and neurological disorders. As with many synthetic cannabinoids, the safety, efficacy, and potential side effects of this compound would require thorough investigation through preclinical and clinical studies. Overall, its unique interaction with cannabinoid receptors positions it as a significant subject of study in medicinal chemistry and pharmacology.

di-coupled CBDP (Item No. 41323) is an analytical reference standard that is structurally similar to known phytocannabinoids. di-coupled CBDP is a dialkylated form of CBDP (Item Nos. 33611 | 30169) and a byproduct formed in the synthesis of CBDP.1 This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.

CB1/2 receptor-1

1260669-31-5: The substance referred to as "CB1/2 receptor-1" with the CAS number 1260669-31-5 is a synthetic compound that acts as a cannabinoid receptor agonist. It is designed to interact with the cannabinoid receptors CB1 and CB2, which are part of the endocannabinoid system in the body. These receptors play crucial roles in various physiological processes, including pain sensation, mood regulation, and immune response. The compound is typically characterized by its ability to modulate neurotransmitter release and influence various signaling pathways. Its pharmacological profile may include analgesic, anti-inflammatory, and neuroprotective effects, making it of interest in therapeutic research, particularly in the context of pain management and neurological disorders. As with many synthetic cannabinoids, the safety, efficacy, and potential side effects of this compound would require thorough investigation through preclinical and clinical studies. Overall, its unique interaction with cannabinoid receptors positions it as a significant subject of study in medicinal chemistry and pharmacology.

CB1/2 receptor-1 (compound 5.3) serves as an agonist for CB1/2 receptors and is utilized in angiogenesis research.

CAS 1260669-31-5

CB1/2 receptor-1

CB1/2 receptor-1

Ref: TM-T200966